ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO784

CKD Is Associated with a Pro-Angiogenic and Inflammatory Profile Even in Post-Transplant CKD

Session Information

  • CKD: Mechanisms - III
    November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2103 CKD (Non-Dialysis): Mechanisms

Authors

  • Jalal, Diana I., University of Iowa, Iowa City, Iowa, United States
  • Renner, Brandon, University of Colorado Denver Med Campus, Aurora, Colorado, United States
  • Ten eyck, Patrick, University of Iowa, Iowa City, Iowa, United States
  • Laskowski, Jennifer, University of Colorado School of Medicine, Greenwood Village, Colorado, United States
  • Cooper, James E., University of Colorado at Denver, Denver, Colorado, United States
  • Sun, Mingyao, University of Iowa, Iowa City, Iowa, United States
  • Attanasio, Massimo, University of Iowa, Iowa City, Iowa, United States
  • Thurman, Joshua M., University of Colorado School of Medicine, Greenwood Village, Colorado, United States
Background

Cardiovascular disease (CVD) is the most common cause of death in native and post-transplant chronic kidney disease (CKD). Circulating microparticles (MP) are increased in CKD and may reflect vascular injury and inflammation, important non-traditional risk factors for CVD. Here, we sought to identify novel biomarkers of vascular injury and inflammation common in both native and post-transplant CKD.

Methods

Proteomic analyses were conducted on plasma and MP of 9 healthy controls, 9 stage 3/4 native CKD patients, and 9 stage 3/4 post-transplant CKD patients. Somalogic SOMAscan assay, a highly sensitive assay that uses aptamers to quantify >1,300 proteins, was used. Ingenuity pathway analyses (IPA) were conducted.

Results

We identified 44 plasma proteins common to both native and post-transplant CKD vs healthy controls; the most significant being angiogenic proteins. IPA indicated Ephrin receptor signaling, serine biosynthesis, and transforming growth factor (TGF)-β as the top pathways activated in both CKD groups. The MP analyses indicated higher levels of 18 proteins common in both native and post-transplant CKD patients vs healthy controls. These proteins included cystatin C, β2-microglobulin, and renin precursor protein. Biomarkers of inflammation and fibrosis were most pronounced with IPA indicating acute phase response, insulin-like growth factor-1, tumor necrosis factor-α, and interleukin-6 signaling activation.

Conclusion

We have identified new putative pathways of vascular injury and inflammation in CKD. Pathways of angiogenesis and inflammation were significantly activated in CKD patients’ plasma and MPs, respectively. Considering the high levels of MP renin precursor protein, the MPs most likely originated in the kidney. The activated pathways common in both native and post-transplant CKD suggest similar mechanisms of CVD in both groups of CKD.

Funding

  • NIDDK Support